JYNT Q3 FY26 earnings call: key takeaways

• Revenue increased 1% year-over-year to $13.6 million (13:44)
• Outlook: full-year system-wide sales of $508 million to $512 million (32:48)

Results vs expectations

What changed since last quarter

• The company raised its full-year 2026 system-wide sales guidance to $508 million to $512 million, down from the previous range of $519 million to $515 million. (32:48)
• The company revised its system-wide comp sales guidance to a range of negative 3.5% to negative 2.5%, down from the prior range of negative 3% to positive 3%. (32:48)
• The CFO mentioned that the company expects free cash flow to improve as remaining ownership transfers are completed. (27:39)

Guidance

What analysts pressed on

• How much of the same store comp sales decline is due to consumer weakness versus franchisee performance. (41:14)
• What factors are contributing to the lower average patient spend per month despite improved membership metrics. (37:30)
• How the company plans to address the $2 per month spend dilution from flexible membership plans. (37:30)

In their words

• We are encouraged by progress in several of our leading patient metrics Sanjeev Rassan (13:44)
• We are confident that the underlying operating indicators are moving in the right direction Sanjeev (34:14)
• We are now working to double down on retention and double down on improving our conversion (39:22)
• We feel like we have that playbook, and we are not allowing any clinic to open without compliance with that playbook Jeremy Perlman (35:28)